BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25561817)

  • 1. Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure.
    Li HM; Ye ZH; Zhang J; Gao X; Chen YM; Yao X; Gu JX; Zhan L; Ji Y; Xu JL; Zeng YH; Yang F; Xiao L; Sheng GG; Xin W; Long Q; Zhu QJ; Shi ZH; Ruan LG; Yang JY; Li CC; Wu HB; Chen SD; Luo XL
    World J Gastroenterol; 2014 Dec; 20(48):18458-65. PubMed ID: 25561817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A prospective cohort study on the influence of high doses of herbs for clearing heat and resolving stasis on survival rates in patients with hepatitis B-related acute-on-chronic liver failure].
    Hu XY; Zhang Y; Chen G; Zhong S; Fan XJ
    Zhong Xi Yi Jie He Xue Bao; 2012 Feb; 10(2):176-85. PubMed ID: 22313885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.
    Guo YM; Li FY; Gong M; Zhang L; Wang JB; Xiao XH; Li J; Zhao YL; Wang LF; Zhang XF
    Chin J Integr Med; 2016 Aug; 22(8):573-80. PubMed ID: 27220737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of integrative medical program based on blood cooling and detoxification recipe in treating patients with hepatitis B virus related acute-on-chronic liver failure: a randomized controlled clinical study].
    Liu HM; Wang XB; Hou YX; Gao FY; Sun FX; Jiang YY; Yang ZY; Du HB; Wang XJ; Zhou GQ; Yang YY; Wang RB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Apr; 34(4):412-7. PubMed ID: 24812894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
    Wang YJ; He LQ; Sun W; Lu Y; Wang XQ; Zhang PQ; Wei LB; Cao SL; Yang NZ; Ma HZ; Gao J; Li P; Tao XJ; Yuan FH; Li J; Yao C; Liu X
    J Ethnopharmacol; 2012 Feb; 139(3):757-64. PubMed ID: 22178174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Traditional Chinese medicine regulating liver regeneration" treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data.
    Dai L; Gao X; Ye Z; Li H; Yao X; Lu D; Wu N
    Front Med; 2021 Jun; 15(3):495-505. PubMed ID: 33433899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L; Chen H; Fan C; Gong Z
    J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic efficacy and quality of life investigation of traditional Chinese medicine-based therapy of chronic hepatitis B-related liver fibrosis].
    An J; Ni W; Qiao J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):30-2. PubMed ID: 24721240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The protective effect of Xuebijing injection pretreatment on hepatic ischemia reperfusion injury and coagulopathy after excision of liver cancer].
    Shen J; Lin XJ; Cui BK; Chi PD; Zeng QY; Zhao QY
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Dec; 25(12):743-8. PubMed ID: 24620386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
    Liu SY; Zhang YQ; Liu YL; Guo P; Zhou CM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1457-61. PubMed ID: 24483103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The short-term efficacy of antiviral treatment in patients with acute-on-chronic hepatitis B liver failure].
    Xu QH; Chen LB; Xu Z; Shu X; Chen N; Cao H; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):467-9. PubMed ID: 20718359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.
    Peng L; Xie DY; Lin BL; Liu J; Zhu HP; Xie C; Zheng YB; Gao ZL
    Hepatology; 2011 Sep; 54(3):820-8. PubMed ID: 21608000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
    BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact and long-term effect of three prescriptions regulating and tonifying lung and kidney on JAK/STAT signaling in rats].
    Tian YG; Li Y; Li JS; Li SY; Jiang SL; Wang Y; Deng L; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):75-80. PubMed ID: 23596881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study.
    Yuen MF; Tam S; Fung J; Wong DK; Wong BC; Lai CL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1179-86. PubMed ID: 17014576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
    Yang HZ; Wang FL; Wang YZ; Shen WS; Xu GL; Yang YW; Huang XL
    Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of the use of Xuebijing injection during laparotomy on perioperative inflammatory response and organ function].
    Zhou X; Li H; Xie G; Fang J; Lian Y; Fang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Apr; 26(4):258-63. PubMed ID: 24709499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.